pGEX Crk-SH2 Citations (2)

Originally described in: High-throughput phosphotyrosine profiling using SH2 domains.
Machida K, Thompson CM, Dierck K, Jablonowski K, Karkkainen S, Liu B, Zhang H, Nash PD, Newman DK, Nollau P, Pawson T, Renkema GH, Saksela K, Schiller MR, Shin DG, Mayer BJ Mol Cell. 2007 Jun 22;26(6):899-915. PubMed Journal

---

Articles Citing pGEX Crk-SH2

Articles
Prophylactic treatment with the c-Abl inhibitor, neurotinib, diminishes neuronal damage and the convulsive state in pilocarpine-induced mice. Chandia-Cristi A, Gutierrez DA, Dulcey AE, Lara M, Vargas L, Lin YH, Jimenez-Munoz P, Larenas G, Xu X, Wang A, Owens A, Dextras C, Chen Y, Pinto C, Marin T, Almarza-Salazar H, Acevedo K, Cancino GI, Hu X, Rojas P, Ferrer M, Southall N, Henderson MJ, Zanlungo S, Marugan JJ, Alvarez R A. Cell Rep. 2024 May 28;43(5):114144. doi: 10.1016/j.celrep.2024.114144. Epub 2024 Apr 23. PubMed
ABL kinase-dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains. Cousens PM, Chandler BW, Schmoker AM, Weinert JL, Kearns CA, Yacawych WT, Semic A, Ebert AM, Ballif BA. FEBS Lett. 2026 Jun 22. doi: 10.1002/1873-3468.70398. PubMed

If you have published an article using this material, please email us at to have your article added to this page.